Tigecycline.
Wenzel
Richard
R
Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA. rwenzel@mcvh-vcu.edu
Bate
Guy
G
Kirkpatrick
Peter
P
D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical / Q000191:economics / Q000379:methods / Q000639:trends; D017277:Drug Approval / Q000331:legislation & jurisprudence; D006801:Humans; D007239:Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D007275:Injections, Intravenous / Q000191:economics / Q000379:methods; D015201:Meta-Analysis as Topic; D008911:Minocycline / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D015394:Molecular Structure; D013678:Technology, Pharmaceutical / Q000191:economics / Q000379:methods / Q000639:trends; D000078304:Tigecycline
D000900:Anti-Bacterial Agents; D000078304:Tigecycline; D008911:Minocycline